The phrase "acid rebound" is correct and usable in written English.
It can be used in contexts related to health, particularly in discussions about stomach acid and digestive issues.
Example: "After taking the antacid, I experienced an acid rebound that made my symptoms worse."
Alternatives: "acid rebound effect" or "rebound acidity".
The relative level of fatty acid rebound after cessation of NiAc administration was also quantified in the two rat populations.
In theory, the higher relapse rates in patients initially treated with esomeprazole who then received placebo during the maintenance phase could be attributed to acid rebound.
However, it is difficult to distinguish between acid rebound and recurrence of initial symptoms, the latter of which seems more likely.
The favorable effect of PPIs on many acid-related diseases was also shown by the exacerbation of GERD symptoms and impairment of HRQL after their discontinuation, probably due to acid rebound hypersecretion [ 23, 33].
Even a stop of at least 2 weeks was mandatory to enter the study, we can not exclude that the effects of long-term therapy in the past or the changes induced by the 2-week stop of medication (e.g. acid rebound) [ 64] could have affect the expression of the five genes studied.
Therefore, eating smaller meals can reduce the chances of acid rebound.
The results of studies evaluating rebound acid hypersecretion (RAHS) following withdrawal of PPI therapy are conflicting.
However, pending consistent and compelling data that withdrawal of PPIs produces acid or symptom rebound in patients that results in PPI dependence, we see no reason for clinicians to alter their prescribing habits.
Although our analysis clearly showed no evidence of acid or symptom rebound that could provoke PPI dependence, we cannot infer the effect of withdrawing patients from long-term PPI therapy based on data from a short-term analysis.
The ammonium rebound acid-loading technique (Thomas, 1984) was used to acidify the cells and cells were incubated in the isotonic solution containing 20 m M NH4Cl for 10 min.
Reversible inhibition of H,K-ATPase by ML 3000 offers the potential for less profound inhibition of acid secretion, thereby attenuating rebound acid hypersecretion which has been reported in H. pylori-negative subjects after omeprazole treatment [ 30].
